An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
about
Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune diseaseThe Role of microRNAs in the Pathogenesis of Herpesvirus InfectionEpstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationThe role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differencesNew and emerging immune-targeted drugs for the treatment of multiple sclerosisEnvironmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsThe inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitisIs Multiple Sclerosis an Autoimmune Disease?Infectious mononucleosis.Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosisProgress, prospects, and problems in Epstein-Barr virus vaccine development.Exposure to the Epstein-Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In VivoObesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors.Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration.Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findingsExpression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.Geographical variations in sex ratio trends over time in multiple sclerosis.Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.Protective environmental factors for neuromyelitis opticaIncreased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosisRelationship of UV exposure to prevalence of multiple sclerosis in England.Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?Epstein-barr virus vaccines.Role of pathogens in multiple sclerosisAnti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosisVaricella zoster virus and relapsing remitting multiple sclerosis.The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's DiseaseEpstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis.Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosisEpigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?What is the Real Fate of Vitamin D in Multiple Sclerosis?Cow's milk allergy in multiple sclerosis patientsInnate immune responses against Epstein Barr virus infectionSystematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus
P2860
Q21135577-40C26D9D-2EBE-41A2-91CF-E7884DD6CE5FQ26748350-21461B3E-E629-4D85-B1B0-942B3E5BE723Q26830464-FB0469C2-EBF2-4CAD-BC3D-A6175AA4C5C5Q26866256-4C522A23-A5D4-4298-A61E-CC4138FE44E7Q26997067-488F112D-17E1-482F-A77E-5C2C0BC64C21Q27006548-B4C2308C-75BB-40A9-A942-A0D75EE64883Q27325503-E7CC6300-0AD4-4236-BF7E-306744837995Q27496011-F0480A12-6790-43D9-BA2D-CC99094E7F1AQ28084340-CD12D91B-50B5-4A5F-A828-F82C46DADBECQ28731829-4DA42450-4F17-4FC8-BF65-943AA2C8A235Q33812640-7DD4834F-1652-4EFA-896B-8EF12B730D32Q33875219-89651FA4-1D54-4FBC-BE39-015800CED6E9Q34266877-8CE17CAD-328B-4F7B-BA12-5E6D3C1CCF0BQ34303664-C3995BA8-BFE0-4071-BE0C-3B66626EB500Q34347671-28574180-27CC-4EC2-8053-4D625CAB85A1Q34427836-A5825FCC-CDF1-461F-9D2C-CCA00EC5EFF5Q34469310-CF514722-4849-4939-9E78-15D1F6E437B4Q34515198-8920DDCA-EE42-48AE-90B9-F0F59165AEEDQ34591273-C6DA1EE3-98FF-45DA-8887-B767E5A2C07AQ34671815-47E52347-C967-4DF4-A625-71E3070957CAQ34922597-FBAAF53D-0A8C-4E3A-AC1E-E8410CC774C2Q35043515-3D608362-5DE4-46F5-8012-09DC50ED3849Q35053650-D5A2B6D9-B2E2-4AC0-90AE-BAFCCCA2F13AQ35206805-DF846B97-6CCE-4F09-9113-3F54BAA3FF7FQ35231431-C275A438-0FF8-45DD-BF9C-E82C887CAFCDQ35231795-F62F21EE-5328-42EB-B7B0-CBF007B0D5FFQ35374873-E64B31DA-4F36-480B-9A40-9B0612C6CCFFQ35687324-B6F66E8C-EDD9-4F60-80B8-0A909AF568C4Q35697927-4A472FFE-FD34-46FD-B7E4-21DA63E05AFFQ35956144-9E81C47C-F4E9-4723-8430-C329A080A081Q36290143-3F248601-A634-40D8-9EE0-9A37D18CF0A0Q36339988-A4B07FDF-A965-4BF3-B215-3E66E6138795Q36399124-437417AE-EDE3-4BBB-BACB-38824C14CD2CQ36421911-A9A6517A-0DD1-4D3A-8445-24322F5658E9Q36638670-013D9DE1-1AD5-4220-BA55-585AE461FBE9Q36648907-A4A11E2D-5C0F-455C-8E72-14A0435F243AQ36917702-C0393B8A-0FE9-48D5-A563-13C3C6472A67Q37095027-4B822721-9F85-44EE-9758-CD26A6726488Q37309928-F8A09AFF-36D0-4B3A-B6C0-728BF4DCDE01Q37690544-746BEDD6-1EA7-4FBF-893B-DE350856DE18
P2860
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An updated meta-analysis of ri ...... wing infectious mononucleosis.
@ast
An updated meta-analysis of ri ...... wing infectious mononucleosis.
@en
type
label
An updated meta-analysis of ri ...... wing infectious mononucleosis.
@ast
An updated meta-analysis of ri ...... wing infectious mononucleosis.
@en
prefLabel
An updated meta-analysis of ri ...... wing infectious mononucleosis.
@ast
An updated meta-analysis of ri ...... wing infectious mononucleosis.
@en
P2093
P2860
P1433
P1476
An updated meta-analysis of ri ...... wing infectious mononucleosis.
@en
P2093
Adam E Handel
Alexander J Williamson
Giulio Disanto
Lahiru Handunnetthi
Sreeram V Ramagopalan
P2860
P356
10.1371/JOURNAL.PONE.0012496
P407
P577
2010-09-01T00:00:00Z